Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study was to evaluate ovicidal efficacy of a single application of
abametapir lotion 0.74% w/w intended for the treatment of head lice.
Phase:
Phase 2
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited Hatchtech Pty Ltd